NAMI - National Alliance on Mental Illness Home | About NAMI | Contact Us | En Espanol  | Donate  
Find
  Advanced Search  
 

Sign In
myNAMI
Communities
Register and Join
Donate
What's New
State & Local NAMIs
Advocate Magazine
NAMI Newsroom
NAMI Store
NAMIWALKS
National Convention
Special Needs Estate Planning
NAMI Travel

 All Discussion Groups

Print this page
Graphic Site
Log Out
 | Print this page | 
 | 
all_discussion_groups

Facts on Access to Medications for People
with Depressive, Bipolar and Anxiety Illnesses

Conclusion

 
  • Access to anti-depressant, anti-anxiety and anti-convulsant medications versus barriers to treatment can mean the difference between hope and despair, recovery and struggle, life and death.
 
  • The stream of new medications that has reached millions of people with depressive, bipolar and anxiety disorders holds enormous potential.
  • Yet, barriers are being imposed by state policymakers that restrict access to needed medications for people with these disorders.
Based on the uniqueness of the medications and the individual patient characteristics of depressive, bipolar and anxiety disorders, it is critically important for state legislators to preserve and/or restore state funding for medications for people with depressive, bipolar and anxiety disorders.
  • Given many states’ budget crises, some may be tempted to limit access to medication and cut funding for services for those with mental illness. However, this is not the way to create an effective, efficient mental health system for those served by Medicaid and other public programs.
 
  • Access to medications for people with depressive, bipolar and anxiety disorders is essential for achieving the best possible clinical outcome as quickly as possible, which leads to the most cost-effective policy for legislators and physicians.
  • Based on the uniqueness of the medications and the individual patient characteristics of depressive, bipolar and anxiety disorders, it is critically important for state legislators to preserve and/or restore state funding for medications for people with depressive, bipolar and anxiety disorders.

Policymakers Toolkit Home


 | Print this page | 
 | 

Home  |  myNAMI  |  About NAMI  |  Contact Us  |  Jobs  |  SiteMap

Copyright © 1996 - 2011 NAMI. All Rights Reserved.